Literature DB >> 9012578

Osmotherapy. Basic concepts and controversies.

R P Paczynski1.   

Abstract

Osmotherapy with compounds such as mannitol has become a mainstay of neurologic and neurosurgical intensive care. Elevated intracranial pressure is the most common indication. A substantive debate remains as to the appropriate timing of administration and the optimal fluid management protocol, and experts disagree about the clinically relevant mechanisms of action of osmotic diuretics. This article briefly summarizes the basic literature on the physical actions of mannitol, addresses commonly asked questions, and highlights some of the controversies that arise at the bedside.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9012578     DOI: 10.1016/s0749-0704(05)70298-0

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  23 in total

Review 1.  Hypertonic saline for cerebral edema.

Authors:  Alexandros L Georgiadis; José I Suarez
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 5.081

Review 2.  Management of intracranial hypertension.

Authors:  Sunit C Singhi; Lokesh Tiwari
Journal:  Indian J Pediatr       Date:  2009-05-24       Impact factor: 1.967

3.  Effect of Hyperosmolar Therapy on Outcome Following Spontaneous Intracerebral Hemorrhage: Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) Study.

Authors:  Manan Shah; Lee Birnbaum; Jennifer Rasmussen; Padmini Sekar; Charles J Moomaw; Jennifer Osborne; Anastasia Vashkevich; Daniel Woo
Journal:  J Stroke Cerebrovasc Dis       Date:  2018-01-03       Impact factor: 2.136

4.  Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients.

Authors:  Carole Ichai; Guy Armando; Jean-Christophe Orban; Frederic Berthier; Laurent Rami; Corine Samat-Long; Dominique Grimaud; Xavier Leverve
Journal:  Intensive Care Med       Date:  2008-09-20       Impact factor: 17.440

5.  Hypertonic saline reduces intracranial hypertension in the presence of high serum and cerebrospinal fluid osmolalities.

Authors:  Eduardo Paredes-Andrade; Craig A Solid; Sarah B Rockswold; Rick M Odland; Gaylan L Rockswold
Journal:  Neurocrit Care       Date:  2012-10       Impact factor: 3.210

6.  Half-molar sodium lactate infusion to prevent intracranial hypertensive episodes in severe traumatic brain injured patients: a randomized controlled trial.

Authors:  Carole Ichai; Jean-François Payen; Jean-Christophe Orban; Hervé Quintard; Hubert Roth; Robin Legrand; Gilles Francony; Xavier M Leverve
Journal:  Intensive Care Med       Date:  2013-06-08       Impact factor: 17.440

Review 7.  Osmotherapy for elevated intracranial pressure: a critical reappraisal.

Authors:  R Nau
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

Review 8.  Osmotherapy in neurocritical care.

Authors:  Anish Bhardwaj
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

9.  The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema.

Authors:  Emil Zeynalov; Chih-Hung Chen; Stanley C Froehner; Marvin E Adams; Ole Petter Ottersen; Mahmood Amiry-Moghaddam; Anish Bhardwaj
Journal:  Crit Care Med       Date:  2008-09       Impact factor: 7.598

10.  Infarct volume after hyperacute infusion of hypertonic saline in a rat model of acute embolic stroke.

Authors:  Alexander Papangelou; Thomas J K Toung; Allan Gottschalk; Marek A Mirski; Raymond C Koehler
Journal:  Neurocrit Care       Date:  2013-02       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.